Verastem competitorsClear all

Verastem's top competitors include Del Mar Pharmaceuticals, Ablynx, Genocea Biosciences and Calithera Biosciences.
Verastem
Verastem
Verastem is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells.
Del Mar Pharmaceuticals
Del Mar Pharmaceuticals
DelMar Pharmaceuticals is engaged in developing and commercializing therapies for the treatment of cancer patients.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
Calithera Biosciences
Calithera Biosciences
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Founding Date
Founding Date
2010
Founding Date
2010
Founding Date
2001
Founding Date
2006
Founding Date
2010
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Needham, US HQ
Walsrode, DE
Locations
San Diego, US HQ
Vancouver, CA
Menlo Park, US
Locations
Gent, BE HQ
Gent, BE
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
169145% increase
Employees
250% decrease
Employees
3942% decrease
Employees
593% decrease
Employees
798% increase
Valuation ($)
Valuation ($)
268.2 m
Valuation ($)
15.4 m
Valuation ($)
N/A
Valuation ($)
104.3 m
Valuation ($)
352.1 m
Twitter followers
Twitter followers
2.4 k
Twitter followers
N/A
Twitter followers
252
Twitter followers
1.5 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
14
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.4
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
242481
Alexa Website Rank
349383
Alexa Website Rank
536319
Alexa Website Rank
187589
Alexa Website Rank
375410
Employee Rating
Employee Rating
4.6
Employee Rating
N/A
Employee Rating
3.1
Employee Rating
3.6
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$17.5m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($149.2m) (FY, 2019)
Net income
N/A
Net income
(€1.1m) (FY, 2016)
Net income
($39m) (FY, 2019)
Net income
($89.9m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 70m
Total funding raised
$ 19.5m
Total funding raised
$ 498.8m
Total funding raised
$ 209.5m
Total funding raised
$ 105m
For sources of this data, please see the company profile

View company profiles

Del Mar Pharmaceuticals
HQ
San Diego, US
Employees
2↓ 50% decrease

DelMar Pharmaceuticals is engaged in developing and commercializing therapies for the treatment of cancer patients.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.

View company
Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

View company